03.19.21

EMA’s Blood Clot Review Exonerates AstraZeneca COVID-19 Vaccine, But Monitoring Continues

Source: FirstWord

03.16.21

EMA Continues Safety Probe of AstraZeneca’s COVID-19 Vaccine as More Countries Halt Use

Source: FirstWord

03.12.21

EU Greenlights J&J’s Coronavirus Vaccine

Source: FirstWord

02.17.21

J&J Submits Single-Dose COVID-19 Vaccine for EMA Review

Source: FirstWord

01.13.21

EMA Receives Conditional Marketing Request for AstraZeneca’s COVID-19 Vaccine

Source: FirstWord

01.07.21

Moderna’s COVID-19 Vaccine Becomes Second to Nab EU Authorization

Source: FirstWord

11.03.20

GenSight Biologics Reports Validation of Lumevoq Marketing Authorization Application (MAA) by European Medicines Agency

Source: GenSight Biologics

10.06.20

Samsung Bioepis and Biogen Announce EMA Filing Acceptance of Proposed Lucentis Biosimilar

Source: Samsung Bioepis

10.02.20

EMA Starts Rolling Review of AstraZeneca’s COVID-19 Vaccine Candidate AZD1222

Source: FirstWord

06.29.20

Novartis Withdraws Marketing Application of Dry Eye Drug Xiidra in Europe

Source: Eyewire News

View more stories